CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

CARDIOCARE presence in IEEE BHI-BSN 2022

Jul 8, 2022

We are really happy to announce that CARDIOCARE will be present at the IEEE-EMBS International Conference in Biomedical and Health Informatics (IEEE BHI-BSN 2022) that will be held in Ioannina on September 27– 30, 2022.

A special session entitled “Artificial intelligence and Real World data for personalised support of patients with cardiovascular diseases” will be organized and supported by the EU funded projects RETENTION, CARDIOCARE, TIMELY and TAXINOMISIS.

The topic concerns artificial intelligence tools and methods developed with existing and/or new data generated by individuals, health professionals and other service providers (including but not limited to data collected through IoT enabled devices, wearables, mobile devices, data source networks or data lakes etc. collected outside the controlled environment of clinical trials). Such real world data are being collected by citizens, healthcare professionals, public authorities and industry, and the developed tools and methods or their conceptual designs aim at personalised risk prediction, prevention and intervention approaches that meet the needs of individuals.

We are looking forward to meeting you and discussing your questions!

Stay in touch for more details about the conference and special session program!

Highlights

Plenary Meeting on 4-5 September 2023 in Milan

The CARDIOCARE plenary meeting took place on 4-5 September 2023 in Milan, Italy. This was the second physical meeting during the project, during which the progress and the various issues for the implementation of the project were discussed. Looking forward to the next...

CARDIOCARE Podcast

CARDIOCARE participated in the ESC Cardio Talk: the podcast series featuring key opinion leaders in cardiovascular medicine. Dr Tsekoura and Dr. Keramida (NKUA) prepared a podcast on Cardiotoxicity in elderly breast cancer patients and it will be sonn public available...